| scholarly article | Q13442814 |
| P50 | author | Thomas P. Monath | Q59762392 |
| P2093 | author name string | Donna Freeman | |
| Arthur K Turner | |||
| Susan Lewis | |||
| Harry Kleanthous | |||
| Patricia Londoño-Arcila | |||
| Michael J Darsley | |||
| Aisling M O'Dowd | |||
| Judith Greenwood | |||
| Emma L Rees | |||
| Timothy J Tibbitts | |||
| P2860 | cites work | Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection | Q24548763 |
| Supramolecular assembly and acid resistance of Helicobacter pylori urease | Q27632025 | ||
| Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. | Q30456762 | ||
| HtrA homologue of Legionella pneumophila: an indispensable element for intracellular infection of mammalian but not protozoan cells | Q30659177 | ||
| Isolation of recombinant protective Helicobacter pylori antigens | Q30756838 | ||
| Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection | Q33755359 | ||
| Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters. | Q33755979 | ||
| Immunization against natural Helicobacter pylori infection in nonhuman primates. | Q33762386 | ||
| Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits | Q33829995 | ||
| In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors | Q34003031 | ||
| Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers | Q34003500 | ||
| Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers | Q34003941 | ||
| Immunization with recombinant Helicobacter pylori urease in specific-pathogen-free rhesus monkeys (Macaca mulatta). | Q34004186 | ||
| Adoptive transfer of CD4+ T cells specific for subunit A of Helicobacter pylori urease reduces H. pylori stomach colonization in mice in the absence of interleukin-4 (IL-4)/IL-13 receptor signaling. | Q34006449 | ||
| Selection for urease activity during Helicobacter pylori infection of rhesus macaques (Macaca mulatta). | Q34007487 | ||
| Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans | Q34008614 | ||
| Helicobacter pylori antibiotic resistance: trends over time | Q34144921 | ||
| Recombinant antigens prepared from the urease subunits of Helicobacter spp.: evidence of protection in a mouse model of gastric infection | Q34544741 | ||
| Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis | Q35398734 | ||
| Urease-specific monoclonal antibodies prevent Helicobacter felis infection in mice | Q35401490 | ||
| Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses | Q36401349 | ||
| The role of a stress-response protein in bacterial virulence | Q37575067 | ||
| Serum immunoglobulin G immune response to Helicobacter pylori antigens in Mongolian gerbils | Q39464027 | ||
| Characterization of candidate live oral Salmonella typhi vaccine strains harboring defined mutations in aroA, aroC, and htrA. | Q39509638 | ||
| Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. | Q39827320 | ||
| Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers | Q40149266 | ||
| Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets | Q40151140 | ||
| A urease-negative mutant of Helicobacter pylori constructed by allelic exchange mutagenesis lacks the ability to colonize the nude mouse stomach. | Q40375054 | ||
| Effect of gastric pH on urease-dependent colonization of gnotobiotic piglets by Helicobacter pylori | Q40375096 | ||
| Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C. | Q40613747 | ||
| Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers | Q40631622 | ||
| Construction of genetically defined double aro mutants of Salmonella typhi | Q40743402 | ||
| In vitro characterization of Salmonella typhi mutant strains for live oral vaccines | Q40761489 | ||
| Isolation of stable aroA mutants of Salmonella typhi Ty2: properties and preliminary characterisation in mice | Q40797598 | ||
| The development of oral vaccines based on live attenuated Salmonella strains | Q40842482 | ||
| Systemic and local immune responses against Helicobacter pylori urease in patients with chronic gastritis: distinct IgA and IgG productive sites | Q42138194 | ||
| Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori | Q43618300 | ||
| Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis | Q43702777 | ||
| Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant. | Q43981500 | ||
| Investigation of effects of anesthesia and age on aspiration in mice through LacZ gene transfer by recombinant E1-deleted adenovirus vectors | Q44016294 | ||
| Systemic immunization with urease protects mice against Helicobacter pylori infection | Q47971087 | ||
| Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans. | Q48014958 | ||
| Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers. | Q50112049 | ||
| A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model | Q50120545 | ||
| Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B. | Q50132011 | ||
| A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens | Q50134864 | ||
| Expression of LacZ from the htrA, nirB and groE promoters in a Salmonella vaccine strain: influence of growth in mammalian cells | Q50144951 | ||
| Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi | Q50146372 | ||
| Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine | Q50174904 | ||
| Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain | Q50181478 | ||
| Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease | Q72718088 | ||
| Local and systemic antibody responses in humans with Helicobacter pylori infection | Q73079725 | ||
| Analysis of host responses of guinea pigs during Helicobacter pylori infection | Q73670177 | ||
| Rapid recurrence of Helicobacter pylori infection in Peruvian patients after successful eradication. Gastrointestinal Physiology Working Group of the Universidad Peruana Cayetano Heredia and The Johns Hopkins University | Q73948566 | ||
| Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults | Q74637084 | ||
| Oral immunization with recombinant Helicobacter pylori urease confers long-lasting immunity against Helicobacter felis infection | Q77297235 | ||
| Serologic IgG response to urease in Helicobacter pylori-infected persons from Mexico | Q77811470 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Helicobacter pylori | Q180556 |
| Helicobacter pylori infectious disease | Q4497153 | ||
| attenuated vaccine | Q1810913 | ||
| Salmonella enterica | Q2264864 | ||
| P304 | page(s) | 5096-5106 | |
| P577 | publication date | 2002-09-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen | |
| P478 | volume | 70 |
| Q41462360 | A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice |
| Q36237899 | A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen |
| Q84729221 | An experimental outer membrane vesicle vaccine from N. meningitidis serogroup B strains that induces serum bactericidal activity to multiple serogroups |
| Q35047221 | Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors |
| Q36374944 | Autodisplay: efficacious surface exposure of antigenic UreA fragments from Helicobacter pylori in Salmonella vaccine strains |
| Q54331823 | Chimeric flagellin as the self-adjuvanting antigen for the activation of immune response against Helicobacter pylori. |
| Q34529634 | Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines |
| Q35036179 | Development of a biosafety enhanced and immunogenic Salmonella enteritidis ghost using an antibiotic resistance gene free plasmid carrying a bacteriophage lysis system |
| Q36538894 | Development of inducible systems to engineer conditional mutants of essential genes of Helicobacter pylori |
| Q36076366 | Diagnosis of Helicobacter pylori infection and diseases associated with Helicobacter pylori by Helicobacter pylori outer membrane proteins |
| Q35923188 | Effect of bacterial flora on postimmunization gastritis following oral vaccination of mice with Helicobacter pylori heat shock protein 60. |
| Q35949699 | Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy |
| Q40206378 | Enhanced immunogenicity in the murine airway mucosa with an attenuated Salmonella live vaccine expressing OprF-OprI from Pseudomonas aeruginosa |
| Q33558850 | Enhanced immunoglobulin A response and protection against Salmonella enterica serovar typhimurium in the absence of the substance P receptor |
| Q37425146 | Evidence for the active role of a novel nuclease from Helicobacter pylori in the horizontal transfer of genetic information. |
| Q39697002 | Expression and display of UreA of Helicobacter acinonychis on the surface of Bacillus subtilis spores |
| Q36213815 | Helicobacter pylori L-form and patients with chronic gastritis |
| Q39110732 | Helicobacter pylori genes involved in avoidance of mutations induced by 8-oxoguanine |
| Q35583570 | Helicobacter pylori– inflammation, immunity and vaccines |
| Q53069345 | Immunogenic characterization and protection against Streptococcus mutans infection induced by intranasal DNA prime-protein boost immunization. |
| Q33996971 | Immunogenicity of Recombinant Helicobacter pylori Urease B Administered by Various Routes and with Different Adjuvants |
| Q40076042 | Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils. |
| Q54347312 | Immunological features and the ability of inhibitory effects on enzymatic activity of an epitope vaccine composed of cholera toxin B subunit and B cell epitope from Helicobacter pylori urease A subunit. |
| Q37051032 | Influence of promoter, gene copy number, and preexisting immunity on humoral and cellular responses to a vectored antigen delivered by a Salmonella enterica vaccine |
| Q51324862 | Inhibition of H. pylori colonization and prevention of gastritis in murine model. |
| Q41184340 | Intranasal immunization with an epitope-based vaccine results in earlier protection, but not better protective efficacy, against Helicobacter pylori compared to subcutaneous immunization |
| Q36209731 | L-forms of H. pylori |
| Q36837160 | Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet? |
| Q35838661 | Mucosal immunity: overcoming the barrier for induction of proximal responses. |
| Q33824782 | Mucosally delivered Salmonella typhi expressing the Yersinia pestis F1 antigen elicits mucosal and systemic immunity early in life and primes the neonatal immune system for a vigorous anamnestic response to parenteral F1 boost |
| Q41062011 | New stable anchor protein and peptide linker suitable for successful spore surface display in B. subtilis |
| Q37349230 | Oral immunization with attenuated Salmonella enterica serovar Typhimurium encoding Cryptosporidium parvum Cp23 and Cp40 antigens induces a specific immune response in mice |
| Q59592118 | Oral priming of mice by recombinant spores of Bacillus subtilis |
| Q24554222 | Pathogen DNA as target for host-generated oxidative stress: role for repair of bacterial DNA damage in Helicobacter pylori colonization |
| Q81156952 | Poliovirus replicons encoding the B subunit of Helicobacter pylori urease protect mice against H. pylori infection |
| Q34268349 | Protective efficacy of recombinant urease B and aluminum hydroxide against Helicobacter pylori infection in a mouse model |
| Q50097465 | Recombinant Salmonella enterica serovar Typhi in a prime-boost strategy |
| Q50053182 | Recombinant outer membrane vesicles to augment antigen-specific live vaccine responses |
| Q37282782 | Role of the N-Acetylmuramoyl-l-Alanyl Amidase, AmiA, of Helicobacter pylori in Peptidoglycan Metabolism, Daughter Cell Separation, and Virulence |
| Q36313476 | Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever |
| Q37106127 | Salmonella enterica serovar Typhi live vector vaccines finally come of age |
| Q41476019 | Stabilization of a plasmid coding for a heterologous antigen in Salmonella enterica serotype typhi vaccine strain CVD908-htrA by using site-specific recombination |
| Q37160943 | Targeted identification of glycosylated proteins in the gastric pathogen Helicobacter pylori (Hp). |
| Q46734851 | The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice |
| Q34143589 | Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: safety, immunogenicity, and efficacy |
| Q34025527 | Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy |
| Q36898558 | Use of mchI encoding immunity to the antimicrobial peptide microcin H47 as a plasmid selection marker in attenuated bacterial live vectors |
Search more.